Zhengye Biotechnology Holding Ltd financial data

Symbol
ZYBT on Nasdaq
Location
Jilin
Latest financial report
20-F - Q4 2024 - 03 Jul 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45,666,376 shares
Common Stock, Shares, Outstanding 45,666,376 shares 0%
Common Stock, Value, Issued $1,000 USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,549,000 USD
Marketable Securities, Current $183,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $8,160,000 USD
Inventory, Net $7,977,000 USD
Assets, Current $24,328,000 USD
Deferred Income Tax Assets, Net $1,506,000 USD
Property, Plant and Equipment, Net $34,957,000 USD
Assets $67,577,000 USD
Accounts Payable, Current $5,885,000 USD
Contract with Customer, Liability, Current $477,000 USD
Liabilities, Current $18,618,000 USD
Liabilities $19,276,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax ¥3,000 CNY
Retained Earnings (Accumulated Deficit) $6,597,000 USD
Stockholders' Equity Attributable to Parent $38,903,000 USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $48,301,000 USD
Liabilities and Equity $67,577,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 2,000,000,000 shares 0%
Common Stock, Shares, Issued 45,666,376 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,549,000 USD -32%
Deferred Tax Assets, Valuation Allowance $18,000 USD
Deferred Tax Assets, Gross $1,524,000 USD
Property, Plant and Equipment, Gross $48,904,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $100,000 USD
Deferred Tax Assets, Net of Valuation Allowance $1,506,000 USD